Menu
+
+
+
+
+
+
In a double-blind, vehicle-controlled Phase I trial in patients undergoing endoscopic removal of urinary stones, OMS201 did not produce serious adverse events....
BioCentury employs a fully integrated multimedia platform — including publications, online data solutions and conferences — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.
